Patent details

EP3355889 Title: DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULATORS FOR USE IN THE TREATMENT OF COUGH

Basic Information

Publication number:
EP3355889
PCT Application Number:
US2016053223
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP168523405
PCT Publication Number:
WO2017058645
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULATORS FOR USE IN THE TREATMENT OF COUGH
French Title of Invention:
MODULATEURS DES RÉCEPTEURS P2X3 ET P2X2/3 DE DIAMINOPYRIMIDINE DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE LA TOUX
German Title of Invention:
DIAMINOPYRIMIDIN-P2X3- UND P2X2/3-REZEPTOR-MODULATOREN ZUR VERWENDUNG BEI DER BEHANDLUNG VON HUSTEN
SPC Number:
LUC00332

Dates

Filing date:
23/09/2016
Grant date:
15/02/2023
EP Publication Date:
08/08/2018
PCT Publication Date:
06/04/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/02/2023
EP B1 Publication Date:
15/02/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
23/09/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/02/2023
 
 

Name:
Afferent Pharmaceuticals Inc.
Address:
126 East Lincoln Avenue Rahway, New Jersey 07065, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
07/04/2023
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
GLAUB, Kathleen Sereda
Address:
United States (US)

2

Name:
SMITH, Steven
Address:
United States (US)

3

Name:
FORD, Anthony, P.
Address:
United States (US)

4

Name:
KITT, Michael, M.
Address:
United States (US)

Priority

1

Priority Number:
201562234584 P
Priority Date:
29/09/2015
Priority Country:
United States (US)

2

Priority Number:
201662336381 P
Priority Date:
13/05/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 9/06; A61K 9/10; A61K 9/20; A61K 9/48; A61K 31/505; A61K 45/06; A61K 47/38; A61K 47/44; A61P 11/14; A61P 43/00;

Publication

European Patent Bulletin

1

Issue number:
202307
Publication date:
15/02/2023
Description:
Grant (B1)

2

Issue number:
202312
Publication date:
22/03/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/09/2025
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Expected Payer:
Last Annual Fee Payment Date:
09/08/2024
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
07/04/2023 Power Of Attorney 1
07/04/2023 Outgoing Correspondence 1